ArticleInternational ophthalmology2026
Upregulation of S100A9 in orbital tissues of patients with thyroid eye disease.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeTo identify the differentially expressed genes in the orbital tissues of patients with thyroid eye disease (TED).
methodsThe microarray datasets on the orbital tissues of TED patients were collected from the Gene Expression Omnibus DataSets. Upon filtering, the differentially expressed genes (DEGs) of the selected dataset were determined and evaluated by gene ontology analysis. The expressions of genes related to the TED pathophysiological changes were validated by SYBR Green polymerase chain reaction (PCR) and immunofluorescence analyses on separate TED and control orbital tissue specimens.
resultsAnalysis on the orbital tissue samples of TED patients in the GSE58331 dataset identified 74 DEGs. Gene ontology analysis revealed that the DEGs are involved in the endocytosis, innate immunity, and extracellular matrix. Out of the 10 selected genes, only S100A9 showed significant upregulation in the orbital tissues of TED patients as compared to that of the control subjects (P = 0.006) in the SYBR Green PCR validation experiment. Immunofluorescence analysis confirmed significantly elevated expression of S100A9 in the orbital tissues of TED patients (P = 0.008). The receiver-operating characteristic curve (ROC) analysis demonstrated that the area under the ROC curve of S100A9 was 0.79 for the discrimination of the TED patients from the control subjects.
conclusionThis study revealed the upregulation of S100A9 in the orbital tissues of TED patients, suggesting that it could be involved in the development of TED.
Indexed as
Identifiers
42463561What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.